Investors Alert: Gilead Sciences Inc. (NASDAQ:GILD), Transition Therapeutics Inc. (NASDAQ:TTHI), Meritage Homes Corporation (NYSE:MTH), Curtiss-Wright Corporation (NYSE:CW)

Gilead Sciences Inc. (NASDAQ:GILD) ended the last trading day at $115.46. Company weekly volatility is calculated as 1.92% and price to cash ratio as 15.02. Gilead Sciences Inc. (NASDAQ:GILD) showed a weekly performance of -4.97%. On 19 June, Gilead Sciences Inc. (NASDAQ:GILD) said that, RBC’s Michael Yee and John Chung have the latest prescription data for Gilead Sciences’ hepatitis C treatment, and are predicting U.S. sale of $3.2 billion for the second quarter, just slightly beating consensus estimates.

Transition Therapeutics Inc. (NASDAQ:TTHI) shares decreased -11.25% in last trading session and ended the day at $2.13. TTHI return on assets is -91.70%. Transition Therapeutics Inc. (NASDAQ:TTHI) quarterly performance is -68.68%. On 25 June, Transition Therapeutics Inc. (NASDAQ:TTHI) announced that a Phase 2/3 clinical study of ELND005 did not meet its primary efficacy endpoint.

On 29 June, Meritage Homes Corporation (NYSE:MTH) shares decreased -3.13% and was closed at $47.02. MTH EPS growth in last 5 year was 29.40%. Meritage Homes Corporation (NYSE:MTH) year to date (YTD) performance is 30.65%. Meritage Homes Corporation (NYSE:MTH) plans to release the Company’s second quarter 2015 results on Wednesday, July 29, 2015 before the market opens.

Curtiss-Wright Corporation (NYSE:CW) shares decreased -1.83% in last trading session and ended the day at $72.58. CW Gross Margin is 34.80% and its return on assets is 3.80%. Curtiss-Wright Corporation (NYSE:CW) quarterly performance is -1.97%.On 15 June, Curtiss-Wright Corporation (NYSE:CW) announced that it has been awarded contracts valued at over $480 million when fully funded to supply pumps, valves, generators and propulsors for the U.S. Navy’s Block IV Virginia Class Submarine Program. The Navy’s Block IV contracts cover 10 submarines, two per year from fiscal years 2014 through 2018.

Leave a Reply

Your email address will not be published. Required fields are marked *